Daily News Podcast

Opioids do more harm than good for musculoskeletal pain

Publish date: June 27, 2018

 

Opioids cannot be justified for the routine treatment for musculoskeletal pain because risks outweigh benefits. Also today, intensive treatment for type 2 diabetes pays off in the long run, diabetes patients are being pushed into high-deductible insurance plans, and obesity didn’t just happen overnight.

Listen to the MDedge Daily News podcast for all the details on today’s top news.

Recommended Reading

Type 2 diabetes may promote Parkinson development
MDedge Dermatology
Routine AAA screening for older men: more harm than good?
MDedge Dermatology
TNF inhibitor linked to one-third drop in total mortality
MDedge Dermatology
Inflammatory myopathy following tattoo reported in an immunocompromised patient
MDedge Dermatology
Galectin-3: A post-MI prognostic biomarker for our times
MDedge Dermatology
Herpesvirus infections may have a pathogenic link to Alzheimer’s disease
MDedge Dermatology
JAK inhibitor therapy promising for refractory dermatomyositis
MDedge Dermatology
Patients going without as insulin prices skyrocket
MDedge Dermatology
Chilblain Lupus Erythematosus Presenting With Bilateral Hemorrhagic Bullae of Distal Halluces
MDedge Dermatology
FDA approves Epidiolex for both Lennox-Gastaut syndrome and Dravet syndrome
MDedge Dermatology